Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case–control study

BackgroundVedolizumab was demonstrated to be safe and effective in adults with moderately to severely active inflammatory bowel disease (IBD) in clinical trials. However, there are limited data regarding its efficacy and safety in elderly patients.MethodsThis was a case–control study comparing the e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gastroenterology Report 2020-08, Vol.8 (4), p.306-311
Hauptverfasser:	Shashi, Preeti, Gopalakrishnan, Dharmesh, Parikh, Malav P, Shen, Bo, Kochhar, Gursimran
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged patients Drug therapy Original Patient outcomes Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!